1. Home
  2. MG vs ESPR Comparison

MG vs ESPR Comparison

Compare MG & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MG
  • ESPR
  • Stock Information
  • Founded
  • MG 1978
  • ESPR 2008
  • Country
  • MG United States
  • ESPR United States
  • Employees
  • MG N/A
  • ESPR N/A
  • Industry
  • MG Military/Government/Technical
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • MG Consumer Discretionary
  • ESPR Health Care
  • Exchange
  • MG Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • MG 366.2M
  • ESPR 319.2M
  • IPO Year
  • MG 2009
  • ESPR 2013
  • Fundamental
  • Price
  • MG $9.19
  • ESPR $2.30
  • Analyst Decision
  • MG Hold
  • ESPR Buy
  • Analyst Count
  • MG 1
  • ESPR 4
  • Target Price
  • MG $11.00
  • ESPR $8.17
  • AVG Volume (30 Days)
  • MG 166.4K
  • ESPR 3.4M
  • Earning Date
  • MG 10-30-2024
  • ESPR 11-07-2024
  • Dividend Yield
  • MG N/A
  • ESPR N/A
  • EPS Growth
  • MG N/A
  • ESPR N/A
  • EPS
  • MG 0.36
  • ESPR N/A
  • Revenue
  • MG $738,983,000.00
  • ESPR $295,451,000.00
  • Revenue This Year
  • MG $8.56
  • ESPR $199.60
  • Revenue Next Year
  • MG $3.97
  • ESPR $19.36
  • P/E Ratio
  • MG $25.49
  • ESPR N/A
  • Revenue Growth
  • MG 6.85
  • ESPR 187.12
  • 52 Week Low
  • MG $5.84
  • ESPR $0.87
  • 52 Week High
  • MG $12.44
  • ESPR $3.40
  • Technical
  • Relative Strength Index (RSI)
  • MG 36.53
  • ESPR 54.58
  • Support Level
  • MG $8.26
  • ESPR $2.05
  • Resistance Level
  • MG $9.64
  • ESPR $2.25
  • Average True Range (ATR)
  • MG 0.50
  • ESPR 0.12
  • MACD
  • MG -0.25
  • ESPR -0.00
  • Stochastic Oscillator
  • MG 24.88
  • ESPR 61.54

About MG Mistras Group Inc

MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: